The effect of Nigella sativa (black seed) and vit. E + selenium in the prevention of liver necrosis experimentally induced with carbon tetrachloride (CCl4) in rats;Karbontetraklorid (CCl4) ile deneysel olarak karaciǧer nekrozu oluşturulan ratlarda vitamin e + selenyum ve Nigella sativa (çörekotu)'nin karaciǧer yikimini engelleyici etkileri

Turkish Journal of Veterinary and Animal Sciences

Volumn 27, Issue 1, 2003, Pages 141-152

  Şahin, Ali ^a   Yener, Zabit ^a   Daǧoǧlu, Gürdal ^a   Dede, Semiha ^a   Oto, Gökhan ^a   Alkan, Musa ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

CCl4; Liver necrosis; Nigella sativa (black seed); Vitamin E + selenium

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CERULOPLASMIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIQUID PARAFFIN; MALONALDEHYDE; NIGELLA SATIVA EXTRACT; SELENIUM; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER NECROSIS; LIVER PROTECTION; NONHUMAN; RAT; WEIGHT REDUCTION;

ANIMALIA; NIGELLA SATIVA;

EID: 0037224492     PISSN: 13000128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Angell, M., Kassier, J.P.: Alcohol and other drugs-toward a more rational and consistent policy. N. Engl. J. Med. 1994; 331: 537-539.
2. Steven, E.H., Ned, H.C.: Alcoholism. Scientific American, Inc., 13 Psychiatry, III Alcoholism, 1-12, 1990.
3. Lieber, C.S.: Medical Disorders of Alcoholism. N. Engl. J. Med. 1995; 333: 1058-1065.
4. Paradis, V., Kollinger, M., Fabre, M., Holstege, A., Poynard, T., Bedossa, P.: In situ detection of lipid peroxidation by products in chronic liver diseases. Hepatology. 1997; 26: 135-142.
5. Britton, R.S., Bacon, B.R.: Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology. 1994; 41: 343-348.
6. Kumar, V., Robins, S.L.: Basic Pathology, Fourth ed., W. B. Saunders Company, pp: 587, 1987.
7. Parola, M., Leonarduzzi, G., Biasi, F., Albano, E., Biocca, M.E., Poli, G., Dianzani, M.U.: Vitamin E Dietary Supplementation Protects against Carbon Tetrachloride-Induced Chronic Liver Damage and Cirrhosis. Hepatology. 1992; 16: 1014-1021.
8. Şanli, Y.: Veteriner Klinik Farmakoloji ve ilaçla Saǧaltim Ilkeleri. Özkan Matbaacilik Ltd. Şti., Ankara, pp: 430, 1999.
9. Saǧlam, K., Bakir, B.: Köpeklerin Termal Yaniklarinda Antioksidanlarin Yara Iyileşmesi üzerine Etkileri. YYÜ. Saǧlik Bilimleri Dergisi. 1999; 5(1-2): 26-37.
10. Lieber, C.S.: Pathogenesis and treatment of liver fibrosis in alcoholics: 1996 update. Dig. Dis. Sci. 1997; 15: 42-46.
11. Dworkin, B.M., Rosenthal, W.S., Stahl, R.E., Panesar, N.K.: Decreased hepatic selenium content in alcoholic cirrhosis. Dig. Dis. Sci. 1988; 33: 1213-1217.
12. Türker, L., Bayrak, A.: Çörekotu (Nigella sativa L.)'nun Sabit ve Uçucu Yaǧ Kompozisyonunun Araştirilmasi. Standard, 1997; 430: 128-137.
13. Aqel, M., Shaheen, R.: Effects of the volatile oil of Nigella sativa seeds on the uterine smooth muscle of rat and guinea pig. J. Ethnopharm. 1996; 52: 23-26.
14. Mahfouz, M., El-Dakhakhny, M.: Some chemical and pharmacologic properties of the new antiasthmatic drug "nigellone". Pharm. Bull. 1960; 42: 411-415.
15. Hanafy, M.S., Hatem, M.E.: Studies on the antimicrobial activity of Nigella sativa seed (black cumin). J. Indiana State Med. Assoc. 1991; 34: 275-278.
16. Salomi, N.J., Nair, S.C., Jayawarahanan, K.K., Varghese, C.D.: Antitumor principles from Nigella sativa seeds. Johns Hopkins Alumni. Mag. 1992; 63(1): 33-36.
17. Daba, M.H., Abdel-Rahman, M.S.: Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol. Lett. 1998; 95(1): 23-29.
18. Beutler, E., Duron, O., Kelly, B.M.: Improved Method for the Determination of Blood Glutathione. J. Lab. Clin. Med. 1963; 61 (5): 882-885.
19. Akkuş, I.: Serbest Radikaller ve Fizyopatolojik Etkileri. Konya, Mimoza Yayinlari, 1995.
20. Yenson, M.: Klinik Biyokimya Laboratuvar Çalişmalari, Beta Yayinlari, 6. Baski, Istanbul, 1986.
21. Düzgüneş, O., Kesici, T., Kavuncu, O., Gürbüz, F.: Araştirma ve Deneme Metotlari (Istatistik Metotlari-1) Ankara Üniv. Zir. Fak. Yay. No: 1021, Ankara, 1987.
22. 4 cirrhosis in rats: irreversible histological changes and differentiated functional impairment. J. Hepatol. 1991; 12: 110-117.
23. Türkdoǧan, M.K., Aǧaoǧlu, Z., Yener, Z., Şekeroǧlu, R., Akkan, H.A., Avci, M.E.: The Role of Antioxidant Vitamins (C and E), Selenium and Nigella sativa in the Prevention of Liver Fibrosis and Cirrhosis in Rabbits: New Hopes. Dtsch. Tierartzl. Wschr. 2001; 108: 71-73.
24. Milli, Ü.M., Haziroǧlu, R.: Veteriner Patoloji II. Cilt. pp: 195, 2000.
25. Müller, G., Rahfeld, B., Tannasch, M.: Malondialdehyde Concentration in Blood Plasma of Patients with Liver Disease. Z. Gesamte. Inn. Med. 1992; 47(6): 263-265.
26. McDonald, C.M.: The Effect of Ethanol on Hepatic Lipid Peroxidation and the Activities of Glutathione Reductase and Peroxidase. Febs Letters. 1973; 35 (2): 218-227.
27. French, S.W., Morimoto M., Reitz, R.C., Koop, D., Klopfenstein, B., Estes, K., Clot, P. Sundberg, M.A., Albabo, E.: Lipid Peroxidation, CYP2E1 and Arachidonic Acid Metabolism in Alcoholic Liver Disease in Rats. J. Nutr. 1977; 127: 907-911.
28. 4 Oxidation. J. Appl. Toxicol. 1994; 14 (6): 453-455.
29. Thresiamma, K.C., Kuttan, R.: Inhibition of liver fibrosis by ellagic acid. Indian J. Physiol. Pharmacol. 1996; 40(4): 363-366.
30. Dashti, H., Jeppson, B., Hagerstrand, I., Hultberg, B., Srinivas, U., Abdulla, M., Bengmark, S.: Thioacetamide- and Carbon Tetrachloride-Induced Liver Cirrhosis. Eur. Surg. Res. 1989; 21: 83-89.
31. Turgut, K., Demir, C., Ok, M., Çiftçi, M.K.: Ultrasonographic Evaluation of the Liver Damage in the Dog with Carbon Tetrachloride in Toxication. Tr. J. of Veterinary and Animal Sciences. 1995; 19: 335-338.
32. Lieber, C.S.: Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Adv. Pharmacol. 1997b; 38: 601-628.
33. Loginov, A.S., Matiustin, B.N., Chebanov, S.M., Reshetniak, V.I.: Cholestasis Assessment by Activity of Antioxidant Enzymes and Composition of Plasma Lipoproteins in Patients with Liver Diseases. Ter. Arkh. 1998: 70(4): 40-42.
34. Ritland, S., Steinnes, E., Skrede, S.: Hepatic Copper Content, Urinary Copper Excretion and Serum Ceruloplasmin in Liver Disease. Scan. J. Gastroent. 1983; 12: 81-88.
35. Van Gool, J., De Nie. I., Smit, J., Zuyderhout, F.M.: Mechanisms by Which Acute Phase Proteins Enhance Development of Liver Fibrosis: Effects on Collagenase and Proly-4-Hydroxylase Activity in the Rat Liver. Exp. Mol. Pathol., 1986; 45(2): 160-170.